Product information and disease descriptionProduct descriptionProduct information
Dosage forms and strengths
2 evidence topics · 2 sources
Investigational product form and route in the pivotal trial
| Registry field | Quoted record |
|---|---|
| Pharmaceutical form | “VIAL FOR INTRAVENOUS USE” |
| Route | “SOLUTION FOR INFUSION” |
| Active substance origin | “Protein - Other” |
Flat-dose intravenous administration in the phase 1b trial
Vial strength and commercial formulation
No evidence found.